Related Experiment Videos
Smoking and vascular impotence. A reason for concern
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|September 13, 1986
Summary
A significant portion of impotence clinic patients (39%) had vasculogenic impotence, often linked to advanced age and heavy smoking. This study explores smoking
Area of Science:
- Urology
- Andrology
- Vascular Medicine
Background:
- Impotence, also known as erectile dysfunction, affects a considerable number of men.
- Vasculogenic impotence, stemming from vascular issues, is a significant subtype.
- Patient demographics and lifestyle factors are crucial in understanding impotence etiology.
Purpose of the Study:
- To investigate the prevalence of vasculogenic impotence in patients attending an impotence clinic.
- To examine the demographic characteristics, particularly age and smoking status, of patients with vasculogenic impotence.
- To discuss the potential contribution of smoking to the development of impotence in older men.
Main Methods:
- Retrospective analysis of patient data from an impotence clinic.
- Classification of impotence based on etiology, with a focus on vasculogenic causes.
- Statistical review of patient age and smoking habits.
Main Results:
- 39% of patients were diagnosed with vasculogenic impotence.
- Patients with vasculogenic impotence were predominantly in a high age group.
- A high percentage (93%) of these patients were smokers.
Conclusions:
- Vasculogenic impotence is a common diagnosis in men presenting with erectile dysfunction.
- Advanced age and a history of heavy smoking are strongly associated with vasculogenic impotence.
- Smoking may play a critical role in the pathogenesis of age-related vasculogenic impotence.